Publications

Schapira, AH, P Barone, RA Hauser, Y Mizuno, O Rascol, M Busse, L Salin, N Juhel, and . 2011. “Extended-Release Pramipexole in Advanced Parkinson Disease: A Randomized Controlled Trial. Neurology 2011;77:767-74.”. Neurology.

Friedman, JH, P Agarwal, R Alcalay, KJ Black, KL Chou, L Cote, P Dayalu, et al. 2011. “Clinical Vignettes in Parkinson’s Disease: A Collection of Unusual Medication-Induced Hallucinations, Delusions, and Compulsive Behaviours.”. Int J Neurosci.

Hauser, RA. 2011. “Future Treatments for Parkinson’s Disease: Surfing the PD Pipeline”. Int J Neurosci.

Rascol, O, CJ Fitzer-Attas, RA Hauser, J Jankovic, A Lang, JW Langston, E Melamed, et al. 2011. “A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson’s Disease (the ADAGIO Study): Prespecified and Post-Hoc Analyses of the Need for Additional Therapies, Changes in UPDRS Scores, and Non-Motor Outcomes”. Lancet Neurol.

Gross, RE, RL Watts, RA Hauser, RA Barkay, H Reichmann, R von Kummer, WG Ondo, E Reissig, W Eisner, and . 2011. “Intrastriatal Transplantation of Microcarrier-Bound Human Retinal Pigment Epithelial Cells versus Sham Surgery in Patients With Advanced Parkinson’s Disease: A Double-Blind, Randomised, Controlled Trial. Lancet Neurol 2011;10:509-519.”. Lancet Neurol.

Sampaio, C, J Bronzova, RA Hauser, AE Lang, O Rascol, SV Van De Witte, and AA Theeuwes. 2011. “Pardoprunox in Early Parkinson’s Disease: Results from 2 Large, Randomized Double-Blind Trials. Mov Disord 2011;26:1464-76.”. Mov Disord.

Hauser, RA, H Reichmann, M Lew, A Asgharian, C Makumi, and KJ Shulman. 2011. “Long-Term, Open-Label Study of Once-Daily Ropinirole Prolonged Release in Early Parkinson’s Disease. Int J Neurosci 2011;121:246-53.”. Int J Neurosci.

Hauser, RA, P Auinger, and Parkinson Study Group. 2011. “Determination of Minimal Clinically Important Change in Early and Advanced Parkinson’s Disease. Mov Disord 2011;26:813-8.”. Mov Disord.

Hauser, RA, M Cantillon, E Pourcher, F Micheli, V Mok, M Onofrj, S Huyck, and K Wolski. 2011. “Preladenant in Patients With Parkinson’s Disease and Motor Fluctuations: A Phase 2, Double-Blind, Randomised Trial. Lancet Neurol 2011;10:221-9.”. Lancet Neurol.

Butterfield, LC, CR Cimino, LE Oelke, RA Hauser, and J Sanchez-Ramos. 2010. “The Independent Influence of Apathy and Depression on Cognitive Functioning in Parkinson’s Disease”. Neuropsychology.